Ann Wojcicki, CEO and co-founder of 23andMe, says she is still planning to take the genetic-testing company private despite ...

The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...

Me will pay $30 million to settle a data breach lawsuit from the 2023 credential stuffing attack that exposed the personal ...

The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan ...

The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.

The biotech company 23andMe has a big mess to clean up after its entire board resigned to protest its CEO’s plans to take the ...

Nearly the entire board of directors for 23andMe has resigned — a move that apparently was news to its overly-optimistic ...

Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...

All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne ...

Shares of DNA-testing company 23andMe Holding Co. tumbled 7% early Wednesday, after the independent directors of the board announced their resignation as part of a dispute with the company’s leader ...

The stock of 23andMe has a consensus Moderate Buy rating based on the views of two Wall Street analysts. One analyst rates the stock a Buy and the other rates it a Hold. There are no Sell ratings ...